FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4228999469> ?p ?o ?g. }

• W4228999469 abstract "Abstract BACKGROUND AND AIMS Patients with end-stage renal disease on haemodialysis (HD) frequently have resistance or hyporesponsiveness (hypoR) to erythropoiesis-stimulating agents (ESAs) and are also often iron deficient. Despite evidence of increased comorbidities impacting outcomes such as treatment response and achieving targeted haemoglobin (Hb) and iron levels, there is substantial residual variability in these outcomes that remains unexplained. The ability to identify higher-risk sub-populations may provide additional opportunities to intervene. Genetic loci associated with Hb concentration have been identified in genome-wide association studies. Genetic risk scores (GRS) that provide a means to aggregate the health-related risk of multiple genetic alleles into a single number for risk assessment have been validated using these variants. We evaluated if GRS associated with Hb concentration, in addition to clinical factors, improves prediction of ESA hypoR, Hb and iron outcomes better than either one used alone. METHOD A collaborative, non-interventional study between GlaxoSmithKline and DaVita enrolled 3192 African American (AA) and European American (EA) HD patients. Patient demographics, laboratory and vital measurements, concomitant medications, and comorbidity records were drawn from Electronic Health Records, with patient blood samples obtained for genetic analysis. We created GRS for transethnic and euro-centric populations for Hb concentrations from the literature, and a GRS specific to EGLN1/2/3 genes. ESA hypoR status, iron replete status, and time weighted Hb concentration were evaluated as outcomes. ESA hypoR for epoetin alfa was defined by an erythropoietin resistance index ≥ 2.0 U/kg/wk/g/L [intravenous (IV)] or ≥ 1.33 U/kg/wk/g/L [subcutaneous (SC)], or dose ≥ 450 U/kg/wk (IV) or ≥ 300 U/kg/wk (SC). Iron replete was defined as a ferritin ≥ 100 ng/mL and transferrin saturation ≥ 20%. Heritability was estimated using genome complex trait analysis (GCTA). All analyses were performed individually for each population (AA and EA). Significant P-value threshold was 0.0167 (0.05/3 main effects). RESULTS None of the genetic risk scores tested had any clinically meaningful association with outcomes. Though the GRS specific to EGLN1/2/3 was significantly associated with Hb concentration (P &lt; .01) in the AA population, the Beta squared effect size (ES) was very low (ES = 0.005). GCTA analyses were inconclusive with moderate heritability (h2 &gt;8%) and high standard error (&gt;30%), suggesting high variability in heritability estimates for outcomes. Ignoring GRS, several baseline measurements were significantly associated with outcomes. Baseline Hb was consistently and significantly associated with ESA hypoR and Hb concentration in both AA and EA populations, while significantly associated with iron replete status in only the EA population (P &lt; .0001). Other variables such as age and baseline albumin were significantly associated with ESA hypoR and iron replete status, but only in either the EA or AA population (Table). Significant differences were also observed in baseline characteristics between the EA and AA patients. AA patients were 8 years younger and on HD for 2 years longer (P &lt; .0001) at enrolment compared with EA patients. Baseline ferritin, creatinine, albumin and hypertensive status were also significantly different at baseline (P &lt; .01). CONCLUSION There was limited utility for genetics in predicting ESA hypoR, haemoglobin and iron outcomes in HD patients in AA and EA populations. GCTA analyses were inconclusive, suggesting high variability in heritability estimates. Significant differences in baseline variables between the AA and EA populations that were also significantly associated with ESA hypoR, haemoglobin and iron outcomes suggested that population-level baseline differences must be considered when identifying at-risk sub-populations." @default.
• W4228999469 created "2022-05-08" @default.
• W4228999469 creator A5000514591 @default.
• W4228999469 creator A5002864905 @default.
• W4228999469 creator A5044144962 @default.
• W4228999469 creator A5057271152 @default.
• W4228999469 creator A5058086747 @default.
• W4228999469 creator A5064451261 @default.
• W4228999469 creator A5072655096 @default.
• W4228999469 creator A5077581482 @default.
• W4228999469 creator A5082182433 @default.
• W4228999469 date "2022-05-01" @default.
• W4228999469 modified "2023-09-26" @default.
• W4228999469 title "MO802: Genetics Plays a Limited Role in ESA-Hyporesponsiveness and Haemoglobin Outcomes in End-Stage Renal Disease Patients on Haemodialysis" @default.
• W4228999469 doi "https://doi.org/10.1093/ndt/gfac081.007" @default.
• W4228999469 hasPublicationYear "2022" @default.
• W4228999469 type Work @default.
• W4228999469 citedByCount "0" @default.
• W4228999469 crossrefType "journal-article" @default.
• W4228999469 hasAuthorship W4228999469A5000514591 @default.
• W4228999469 hasAuthorship W4228999469A5002864905 @default.
• W4228999469 hasAuthorship W4228999469A5044144962 @default.
• W4228999469 hasAuthorship W4228999469A5057271152 @default.
• W4228999469 hasAuthorship W4228999469A5058086747 @default.
• W4228999469 hasAuthorship W4228999469A5064451261 @default.
• W4228999469 hasAuthorship W4228999469A5072655096 @default.
• W4228999469 hasAuthorship W4228999469A5077581482 @default.
• W4228999469 hasAuthorship W4228999469A5082182433 @default.
• W4228999469 hasBestOaLocation W42289994691 @default.
• W4228999469 hasConcept C104317684 @default.
• W4228999469 hasConcept C106208931 @default.
• W4228999469 hasConcept C126322002 @default.
• W4228999469 hasConcept C135763542 @default.
• W4228999469 hasConcept C143998085 @default.
• W4228999469 hasConcept C153209595 @default.
• W4228999469 hasConcept C170734499 @default.
• W4228999469 hasConcept C2778534260 @default.
• W4228999469 hasConcept C2778653478 @default.
• W4228999469 hasConcept C2779134260 @default.
• W4228999469 hasConcept C2779159551 @default.
• W4228999469 hasConcept C3019040382 @default.
• W4228999469 hasConcept C54355233 @default.
• W4228999469 hasConcept C71924100 @default.
• W4228999469 hasConcept C86803240 @default.
• W4228999469 hasConcept C98274493 @default.
• W4228999469 hasConceptScore W4228999469C104317684 @default.
• W4228999469 hasConceptScore W4228999469C106208931 @default.
• W4228999469 hasConceptScore W4228999469C126322002 @default.
• W4228999469 hasConceptScore W4228999469C135763542 @default.
• W4228999469 hasConceptScore W4228999469C143998085 @default.
• W4228999469 hasConceptScore W4228999469C153209595 @default.
• W4228999469 hasConceptScore W4228999469C170734499 @default.
• W4228999469 hasConceptScore W4228999469C2778534260 @default.
• W4228999469 hasConceptScore W4228999469C2778653478 @default.
• W4228999469 hasConceptScore W4228999469C2779134260 @default.
• W4228999469 hasConceptScore W4228999469C2779159551 @default.
• W4228999469 hasConceptScore W4228999469C3019040382 @default.
• W4228999469 hasConceptScore W4228999469C54355233 @default.
• W4228999469 hasConceptScore W4228999469C71924100 @default.
• W4228999469 hasConceptScore W4228999469C86803240 @default.
• W4228999469 hasConceptScore W4228999469C98274493 @default.
• W4228999469 hasIssue "Supplement_3" @default.
• W4228999469 hasLocation W42289994691 @default.
• W4228999469 hasOpenAccess W4228999469 @default.
• W4228999469 hasPrimaryLocation W42289994691 @default.
• W4228999469 hasRelatedWork W1540807578 @default.
• W4228999469 hasRelatedWork W1997945890 @default.
• W4228999469 hasRelatedWork W2062708279 @default.
• W4228999469 hasRelatedWork W2607164125 @default.
• W4228999469 hasRelatedWork W2789291920 @default.
• W4228999469 hasRelatedWork W3042521120 @default.
• W4228999469 hasRelatedWork W4246108295 @default.
• W4228999469 hasRelatedWork W4248532142 @default.
• W4228999469 hasRelatedWork W4293578718 @default.
• W4228999469 hasRelatedWork W96364705 @default.
• W4228999469 hasVolume "37" @default.
• W4228999469 isParatext "false" @default.
• W4228999469 isRetracted "false" @default.
• W4228999469 workType "article" @default.